BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 36247151)

  • 1. Biomarkers of gastric cancer: current advancement.
    Jiang T; Mei L; Yang X; Sun T; Wang Z; Ji Y
    Heliyon; 2022 Oct; 8(10):e10899. PubMed ID: 36247151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and Circulating Biomarkers of Gastric Cancer.
    Jelski W; Mroczko B
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
    Huang YK; Yu JC
    World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric juice non-coding RNAs as potential biomarkers for gastric cancer.
    Gareev I; Ahmad A; Wang J; Beilerli A; Ilyasova T; Sufianov A; Beylerli O
    Front Physiol; 2023; 14():1179582. PubMed ID: 37179825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
    Beeharry MK; Liu WT; Yan M; Zhu ZG
    World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
    Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
    JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
    Shekari N; Baradaran B; Shanehbandi D; Kazemi T
    Curr Med Chem; 2018 Feb; 25(6):698-714. PubMed ID: 28971758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression profiles of long non-coding RNAs reveal potential biomarkers for identification of human gastric cancer.
    Li C; Liang G; Yao W; Sui J; Shen X; Zhang Y; Ma S; Ye Y; Zhang Z; Zhang W; Yin L; Pu Y
    Oncol Rep; 2016 Mar; 35(3):1529-40. PubMed ID: 26718650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in gastric cancer early diagnosis.
    Necula L; Matei L; Dragu D; Neagu AI; Mambet C; Nedeianu S; Bleotu C; Diaconu CC; Chivu-Economescu M
    World J Gastroenterol; 2019 May; 25(17):2029-2044. PubMed ID: 31114131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer.
    Liu Y; Ding W; Yu W; Zhang Y; Ao X; Wang J
    Mol Ther Oncolytics; 2021 Dec; 23():458-476. PubMed ID: 34901389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scenario and future prospects of microRNAs in gastric cancer: A review.
    Bhat SA; Majid S; Rehman MU
    Iran J Basic Med Sci; 2019 Apr; 22(4):345-352. PubMed ID: 31168337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal Long Non-Coding RNA CEBPA-AS1 Inhibits Tumor Apoptosis and Functions as a Non-Invasive Biomarker for Diagnosis of Gastric Cancer.
    Piao HY; Guo S; Wang Y; Zhang J
    Onco Targets Ther; 2020; 13():1365-1374. PubMed ID: 32110038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating molecular biomarkers into clinical practice for gastric cancer.
    Nakamura S; Kanda M; Kodera Y
    Expert Rev Anticancer Ther; 2019 Sep; 19(9):757-771. PubMed ID: 31437076
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Applications of Liquid Biopsy in Gastric Cancer.
    Chivu-Economescu M; Necula L; Matei L; Dragu D; Bleotu C; Diaconu CC
    Front Med (Lausanne); 2021; 8():749250. PubMed ID: 34651002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
    Yang Z; Guo X; Li G; Shi Y; Li L
    Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free DNA as a liquid biopsy for early detection of gastric cancer.
    Huang ZB; Zhang HT; Yu B; Yu DH
    Oncol Lett; 2021 Jan; 21(1):3. PubMed ID: 33240409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Invasive Early Molecular Detection of Gastric Cancers.
    Yamamoto H; Watanabe Y; Sato Y; Maehata T; Itoh F
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33036473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicle biomarkers in circulation for the diagnosis of gastric cancer: A systematic review and meta‑analysis.
    Xue J; Qin S; Ren N; Guo B; Shi X; Jia E
    Oncol Lett; 2023 Oct; 26(4):423. PubMed ID: 37664665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.